/
/
/

Beryl Drugs Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)24.32
Volume (₹)1,591.00
High (₹)24.99
Upper Circuit28.78
Low (₹)22.60
Lower Circuit19.20
Prev Close23.99
52W High (₹)27.60
Price23.24
52W Low (₹)15.92

Share Market Cap & Key Ratios Overview

M.Cap (₹)12.17 Cr
Div. Yield (%)0.00
PE Ratio19.50
Debt to Equity0.43
Price to Book1.13
Book Value18.70
EPS (TTM)1.23
Face Value10.00
ROE (%)6.30

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
MANKIND-ANSE
BERLDRG-XNSE
LTP
1W Low
1W High
Market cap (₹)
1835-29 (-1.56%)
1828.80
1856.35
4,41,957Cr
9190-215 (-2.29%)
9151.90
9404.95
2,47,576Cr
4850-78.4 (-1.59%)
4840
4986.45
1,89,233Cr
1099-19 (-1.70%)
1099
1135.35
1,11,671Cr
1361-19 (-1.38%)
1347.70
1370.05
1,10,273Cr
1923-13 (-0.67%)
1914.95
1981.45
1,06,460Cr
1149.75+8.95 (0.78%)
1131.05
1181.40
96,906Cr
1664.9-4.1 (-0.25%)
1644.05
1686.95
96,402Cr
2055.35-19.65 (-0.95%)
2050.50
2108.10
95,843Cr
2288.65+42.65 (1.90%)
2221.10
2298.95
94,050Cr
23.24-0.88 (-3.65%)
22.03
24.99
12Cr

Key Highlights of Beryl Drugs Ltd Balance Sheet

Beryl Drugs Ltd balance sheet discloses shareholders' funds of ₹5.09Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹5.09Cr, and the reserves and surplus of the company is ₹4.41Cr.

The company has its non-current liabilities with total liabilities of ₹16.03Cr as of 2025-03-31.

The current liabilities are ₹4.38Cr as of 2025-03-31. At the same time, current assets are ₹9.13Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹6.01Cr, provided in the Beryl Drugs Ltd financial statements.